SUPPLY AGREEMENTSupply Agreement • May 24th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Supply Agreement (the “Agreement”) is entered into as of the 31st day of January, 2007 (the “Effective Date”), by and between Jazz Pharmaceuticals, Inc., a Delaware corporation (together with its subsidiaries, “Jazz Pharmaceuticals”), and Solvay Pharmaceuticals, Inc., a Georgia corporation (“Solvay”).
ORPHAN MEDICAL, INC. AND CATALYTICA PHARMACEUTICALS, INC. XYREM SUPPLY AGREEMENTSupply Agreement • May 24th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • North Carolina
THIS AGREEMENT (“Agreement”) is made as of this 30th day of June, 2000 by and between ORPHAN MEDICAL, INC., a Minnesota corporation, having its principal offices at 13911 Ridgedale Drive, Minnetonka, Minnesota 55305 (“ORPHAN”) and Catalytica Pharmaceuticals, Inc., a Delaware corporation, having its principal offices at Intersection US 13/NC11 and US 264, Greenville, North Carolina 27834 (“Catalytica”).
TRADEMARK LICENSE AGREEMENTTrademark License Agreement • May 24th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations
ORPHAN MEDICAL, INC. SODIUM GAMMA HYDROXYBUTYRATE DEVELOPMENT AND SUPPLY AGREEMENTDevelopment and Supply Agreement • May 24th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • Minnesota
THIS AGREEMENT (“Agreement”) is made as of this 6th day of November, 1996 by and between ORPHAN MEDICAL, INC., a Minnesota corporation, having its principal offices at 13911 Ridgedale Drive, Minnetonka, Minnesota 55305 (“ORPHAN”) and LONZA, INC., a New York corporation, having its principal offices at 17-17 Route 208, Fair Lawn, New Jersey 07410, (“Supplier”).
Amendment No. 1 to Sodium Gamma Hydroxybutyrate Development and Supply AgreementSodium Gamma Hydroxybutyrate Development and Supply Agreement • May 24th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations
Amendment No. 1, dated February 7, 2005 (this “Amendment”), between Orphan Medical, Inc., a Delaware corporation (“Orphan”), and Lonza, Inc., a New York corporation (“Supplier”).
Amendment No.2 to Sodium Gamma Hydroxybutyrate Development and Supply AgreementSodium Gamma Hydroxybutyrate Development and Supply Agreement • May 24th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Amendment No.2 (the “Amendment”) to the Sodium Gamma Hydroxybutyrate Development and Supply Agreement dated November 6, 1996, as amended, is entered into as of March 30, 2007 (the “Execution Date”) between Jazz Pharmaceuticals, Inc., a Delaware corporation (“Jazz Pharmaceuticals”) and Lonza, Inc., a New York corporation (“Supplier”).
AMENDMENT NO. 3 TO XYREM SUPPLY AGREEMENTXyrem Supply Agreement • May 24th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 3 dated this 21st day of March, 2005 (this “Amendment”) to Xyrem Supply Agreement dated June 30, 2000 by and between Orphan Medical, Inc., a Delaware corporation (“ORPHAN”), and DSM Pharmaceuticals, Inc. (formerly, Catalytica Pharmaceuticals, Inc.), a Delaware corporation (“DSM”):
